Aurobindo Pharma has reported results for first quarter ended June 30, 2015.
The company has reported 3.21% rise in its net profit at Rs 406.02 crore for the quarter ended June 30, 2015 as compared to Rs 393.40 crore for the same quarter in the previous year. The company’s total income has increased by 14.70% to Rs 2244.37 crore for the quarter under review from Rs 1956.69 crore for the corresponding quarter of the previous year.
On the consolidated basis, the company has reported 4.09% rise in its net profit after taxes and minority interest at Rs 432.44 crore for the quarter ended June 30, 2015 as compared to Rs 415.43 crore for the same quarter in the previous year. Total income of the company has increased by 14.63% at Rs 3349.47 crore for quarter under review as compared to Rs 2921.88 crore for the quarter ended June 30, 2014.
During the previous year, on December 4, 2014, the company's USA subsidiary Aurobindo Pharma USA Inc. has acquired Natrol LLC, USA. The above Consolidated results for the quarter ended June 30, 2015 and for the quarter ended and year ended March 31, 2015 includes financial results of operations of Natrol LLC, USA from December 4, 2014. The corresponding figures of the quarter ended June 30, 2014 are not comparable.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.40 |
| Dr. Reddys Lab | 1236.50 |
| Cipla | 1234.30 |
| Zydus Lifesciences | 942.40 |
| Lupin | 2332.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: